Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Andreone

Showing results (81-90 of 204) with videos related to

Pageof 21
Sort By:
Viruses|November 27, 2021
A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral TherapyCesare Mazzaro, Luca Quartuccio, Luigi Elio Adinolfi, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 19, 2012
Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis CElisabetta Loggi, Carmela Cursaro, Alessandra Scuteri, et al.
Plos One|June 11, 2013
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levelsElisabetta Loggi, Florian K Bihl, Carmela Cursaro, et al.
Journal of Viral Hepatitis|December 22, 2018
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis BElisabetta Loggi, Ranka Vukotic, Fabio Conti, et al.
Journal of Gastroenterology|December 15, 2017
Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencingGiovanni Vitale, Stefano Gitto, Francesco Raimondi, et al.
Annals of Hepatology|February 21, 2014
Increase of ribavirin dose improves sustained virological response in HCV-genotype 1 patients with a partial response to peg-interferon and ribavirinFabio Conti, Ranka Vukotic, Stefania Lorenzini, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 3, 2010
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner?Maurizio Biselli, Stefano Gitto, Annagiulia Gramenzi, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 6, 2007
Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomised comparative studyFabio Caputo, Giovanni Addolorato, Michela Stoppo, et al.
Journal of Hepatology|July 23, 2023
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trialRanka Vukotic, Roberto Di Donato, Greta Roncarati, et al.
Hepatology International|August 15, 2015
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignanciesAlessia Piluso, Laura Gragnani, Elisa Fognani, et al.
Pageof 21

Showing results (81-90 of 204) with videos related to

Sort By:
Pageof 21
Viruses|November 27, 2021
A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral TherapyCesare Mazzaro, Luca Quartuccio, Luigi Elio Adinolfi, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 19, 2012
Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis CElisabetta Loggi, Carmela Cursaro, Alessandra Scuteri, et al.
Plos One|June 11, 2013
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levelsElisabetta Loggi, Florian K Bihl, Carmela Cursaro, et al.
Journal of Viral Hepatitis|December 22, 2018
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis BElisabetta Loggi, Ranka Vukotic, Fabio Conti, et al.
Journal of Gastroenterology|December 15, 2017
Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencingGiovanni Vitale, Stefano Gitto, Francesco Raimondi, et al.
Annals of Hepatology|February 21, 2014
Increase of ribavirin dose improves sustained virological response in HCV-genotype 1 patients with a partial response to peg-interferon and ribavirinFabio Conti, Ranka Vukotic, Stefania Lorenzini, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 3, 2010
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner?Maurizio Biselli, Stefano Gitto, Annagiulia Gramenzi, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 6, 2007
Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomised comparative studyFabio Caputo, Giovanni Addolorato, Michela Stoppo, et al.
Journal of Hepatology|July 23, 2023
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trialRanka Vukotic, Roberto Di Donato, Greta Roncarati, et al.
Hepatology International|August 15, 2015
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignanciesAlessia Piluso, Laura Gragnani, Elisa Fognani, et al.
Pageof 21